Integer Posts 19 Percent EPS Gain in Q2

Integer (NYSE:ITGR), a leading medical device contract manufacturer, released financial results for Q2 FY2025 on July 24, 2025. The headline news was GAAP revenue reaching $476 million, up 11.4% from Q2 2024 and beating analyst estimates by $11.63 million. Adjusted earnings per share (EPS) came in at $1.55, matching expectations and representing a 19.2% increase year over year. Management raised profit guidance for the rest of the year, reflecting ongoing robust performance, especially in its main Cardio & Vascular product lines. The quarter was marked by continued organic growth, expanding margins, and contributions from recent acquisitions. Overall, the period showed strong operational progress in line with expectations. Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q1 2025 earnings report. Integer is a contract manufacturer specializing in the production of complex medical device components and finished systems. Its customers are large medical technology companies, known as original equipment manufacturers (OEMs), who rely on Integer for designing, engineering, and manufacturing components that go into life-saving devices used in hospitals and clinics worldwide.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool